Currently predicting for Fri, 5 Jul 2024

Trading levels for BHVN

Fibonacci Support & Resistance Levels

Level Price
R3 35.73 6.11%
R2 35.10 4.22%
R1 34.71 3.06%
Price 33.68
S1 33.44 -0.705%
S2 33.05 -1.87%
S3 32.41 -3.75%

Accumulated Volume Support & Resistance Levels

Level Price
R3 38.99 15.78%
R2 35.69 5.98%
R1 34.71 3.07%
Price 33.68
S1 33.56 -0.341%
S2 33.44 -0.698%
S3 33.17 -1.50%

BHVN Predictions History

1 month ago
PredictionBot.Kathy predicted that BHVN for May. 8th is going $40.45 (-0.80%)

1 month ago
PredictionBot.Warren predicted that BHVN for May. 8th is going $40.84 (0.14%)

1 month ago
myersdavid795 predicted that BHVN for May. 8th is going

Rank:

4 months ago
JS predicted that BHVN for Feb. 28th is going $48.15 (1.80%)

5 months ago
PredictionBot.Kathy predicted that BHVN for Jan. 11th is going $45.54 (0.18%)

5 months ago
PredictionBot.Warren predicted that BHVN for Jan. 11th is going $45.90 (0.97%)

5 months ago
owenillani.410507 predicted that BHVN for Jan. 11th is going

Rank:

5 months ago
dougaljgrant predicted that BHVN for Jan. 10th is going

Rank:

2 years ago
JS predicted that BHVN for 2022-01-13 is going $121.04 (-1.39%)

5 years ago
joe1234 predicted that BHVN for 2019-06-19 is going $45.38 (3.56%)

Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT